The Value of Serum Biomarkers (Bc1, Bc2, Bc3) in the Diagnosis of Early Breast Cancer

Creative Commons License

Atahan K., Kupeli H., Gur S., Yigitbasi T., BAŞBINAR Y., Yigit S., ...Daha Fazla

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, cilt.8, sa.2, ss.148-155, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 8 Sayı: 2
  • Basım Tarihi: 2011
  • Doi Numarası: 10.7150/ijms.8.148
  • Dergi Adı: INTERNATIONAL JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.148-155
  • Anahtar Kelimeler: Breast Cancer diagnosis, Serum Biomarkers, Bc1, Bc2, Bc3, TRANSITIONAL-CELL CARCINOMA, SELDI-TOF-MS, PROTEOMIC ANALYSIS, PROSTATE-CANCER, TUMOR-MARKERS, STAGE, CLASSIFICATION, AGE, ADENOCARCINOMA, IDENTIFICATION
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Background: Surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF) is an approach to biomarker discovery that combines chromatography and mass spectrometry. We aimed to consider the efficacy of Bc1, Bc2, and Bc3 serum biomarkers on early detection of breast cancer (BC) in this study.